Capital Wealth Planning, LLC Amgen Inc Transaction History

Capital Wealth Planning, LLC

$10.5 Billion
Q3 2024

A detailed history of Capital Wealth Planning, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Wealth Planning, LLC holds 1,559,775 shares of AMGN stock, worth $449 Million. This represents 4.77% of its overall portfolio holdings.

Number of Shares

1,559,775

Previous 1,226,027 27.22%

Holding current value

$449 Million

Previous $383 Million 31.2%

% of portfolio

4.77%

Previous 4.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $103 Million - $113 Million	333,748 Added 27.22%	1,559,775 $503 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $103 Million - $125 Million	392,727 Added 47.13%	1,226,027 $383 Million
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $223 Million - $270 Million	830,405 Added 28684.11%	833,300 $237 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $71,084 - $80,191	-278 Reduced 8.76%	2,895 $833,000
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $37,607 - $46,691	-172 Reduced 5.14%	3,173 $852,000
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $116,777 - $138,086	-545 Reduced 14.01%	3,345 $742,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $181 Million - $221 Million	-802,361 Reduced 99.52%	3,890 $940,000
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $184 Million - $234 Million	803,216 Added 26465.11%	806,251 $212 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $681,236 - $768,310	3,035 New	3,035 $684,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $651,755 - $725,290	-2,825 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $210,060 - $232,382	-958 Reduced 25.32%	2,825 $683,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $519,474 - $594,491	2,612 Added 223.06%	3,783 $851,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $604,969 - $708,795	-2,850 Reduced 70.88%	1,171 $249,000
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $78.5 Million - $87.1 Million	-336,182 Reduced 98.82%	4,021 $981,000
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $11.3 Million - $13.2 Million	51,007 Added 17.64%	340,203 $84.6 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $12.5 Million - $14.9 Million	57,818 Added 24.99%	289,196 $72.7 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $53 Million - $59 Million	225,909 Added 4130.72%	231,378 $58.8 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $113,542 - $139,332	-574 Reduced 9.5%	5,469 $1.29 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $15,125 - $20,061	83 Added 1.39%	6,043 $1.23 Million
Q4 2019 Feb 26, 2020	SELL	$189.21 - $243.2 $30,462 - $39,155	-161 Reduced 2.63%	5,960 $1.44 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $2,611 - $3,129	15 Added 0.25%	6,121 $1.24 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $574,114 - $672,992	3,444 Added 129.38%	6,106 $1.13 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $361,740 - $407,760	-2,000 Reduced 42.9%	2,662 $0
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $789,882 - $923,076	4,662 New	4,662 $0

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Planning, LLC with notifications on news.

Account

Capital Wealth Planning, LLC Amgen Inc Transaction History